Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed that it enclosed a Press Release issued by the Company titled ‘Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ?1,270 Crores’.
The above information is a part of company’s filings submitted to BSE.